Clinical Trial Update: Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study evaluating the combination of nivolumab and ipilimumab with a TGFβ-15 peptide vaccine and radiotherapy for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• TGFβ-15 Peptide Vaccine
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Inna Chen, MD | Conditions: Pancreatic Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING